Head-to-head · Cost-Efficiency Index
Invigor Medical vs Metaboost Rx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Invigor Medical
Value shoppers who want competitive pricing on both molecules plus a wider wellness/hormone program on one account.
Visit Invigor MedicalMetaboost Rx
Shoppers who don't mind entering an eligibility funnel to get a firm, itemized quote.
Visit Metaboost RxThe verdict
Invigor Medical takes it, leading the Cost-Efficiency Index 88 to 54. Solid mid-market cost on both molecules from an established operator — good value if you also want a broader metabolic and hormone catalog. Metaboost Rx still earns a C — Shoppers who don't mind entering an eligibility funnel to get a firm, itemized quote.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Invigor Medical.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Invigor Medical | Metaboost Rx |
|---|---|---|
| Cost-Efficiency Index | 88/100 | 54/100 |
| Semaglutide / mo | $225/mo (starting dose) | $249/mo (starting dose, compounded) |
| Tirzepatide / mo | $350/mo (starting dose) | $299/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $2,700 | $2,988 |
| Tirzepatide / yr (modeled) | $4,200 | $3,588 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #8 | #324 |
Invigor Medical
88/100Where the value is
- Competitive mid-market 'starting at' pricing on both semaglutide and tirzepatide
- Licensed in all 50 states, with a named Medical Director (Dr. Hamilton) and five named partner compounding pharmacies
- Both molecules published up front for easy cost modeling
The tradeoffs
- Both prices are floors — no dose-tier breakdown is published, so the real cost at a typical maintenance dose is unknown until intake
- The site names five partner pharmacies but never discloses which one fills a given order
Metaboost Rx
54/100Where the value is
- Publishes at least headline starting prices on the homepage, unlike some peers that hide all numbers
- '$0 if not approved' guarantee reduces risk of a wasted consultation fee
- Offers a microdose GLP-1 tier alongside standard semaglutide/tirzepatide
The tradeoffs
- Homepage price and product-page pricing don't match up -- dose tiers and confirmed rates are never shown together
- No named medical director or compounding pharmacy partner disclosed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.